Fda Trial
- All
- News
- Videos
-
Pig Organ Transplants May One Day Outperform Human Donors, Says Leading Surgeon
A US clinical trial using gene-edited pig kidneys has begun, with experts saying xenotransplantation could one day offer safer and more effective alternatives to human donor organs.
-
Elon Musk's Neuralink to Test Brain Chips in Clinical Study in Great Britain
Elon Musk's brain implant company Neuralink said on Thursday it will launch a clinical study in Great Britain to test how its chips can enable patients with severe paralysis to control digital and physical tools with their thoughts.
-
Can Artificial Intelligence Chatbots Really Improve Mental Health
Recently, I found myself pouring my heart out, not to a human, but to a chatbot named Wysa on my phone. It nodded - virtually - asked me how I was feeling and gently suggested trying breathing exercises.
-
Revolutionary New Drug Offers 99.9% Protection Against HIV
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high costs may limit its global impact.
-
FDA Approves Suzetrigine, First Non-Opioid Painkiller in Decades
The FDA has approved suzetrigine, a groundbreaking painkiller that blocks sodium channels to provide opioid-level pain relief without the risks of addiction, sedation, or overdose. Known as Journavx, this drug is the first in over two decades to introduce a new pain relief mechanism. Clinical trials showed it matched opioids in effectiveness but wi...
-
Elon Musk's Neuralink Gets FDA's 'Breakthrough Device' Tag for Implant Aimed at Restoring Vision
Elon Musk's brain-chip startup Neuralink said on Tuesday its experimental implant aimed at restoring vision received the US Food and Drug Administration's "breakthrough device" designation.
-
Neuralink Brain Chip Implant Wires Now Stable in First Patient, Musk Hopes for More Human Trials This Year
Neuralink's first brain chip implant in a human has stabalised, company executives have confirmed this week. The device works by using tiny wires, which are thinner than a human hair, to capture signals from the brain and translate those into actions such as moving a mouse cursor on a computer screen.
-
Elon Musk's Neuralink Receives Approval to Start Brain Implant Human Trial for Paralysis Patients
Billionaire entrepreneur Elon Musk's brain-chip startup Neuralink said on Tuesday it has received approval from an independent review board to begin recruitment for the first human trial of its brain implant for paralysis patients.
-
Jaden Pariat Selected For Ferrari Driver Academy Trials
Rising Indian motorsport star Jaden R Pariat has been invited to the Ferrari Driver Academy (FDA) selection trials, as one of the best young talents in the Asia Pacific and Oceania region
-
Opinion: Would You Let Elon Musk Implant A Device In Your Brain?
Elon Musk's Neuralink received approval last week from the US Food and Drug Administration to conduct human clinical trials, which one former FDA official called "really a big deal."
-
Elon Musk's Neuralink Says It Has FDA Approval for Study of Brain Implants in Humans
Elon Musk's brain-implant company Neuralink on Thursday said the US Food and Drug Administration (FDA) had given the green light to its first-in-human clinical trial, a critical milestone after earlier struggles to gain approval.
-
Neuralink Said to Approach US Neurosurgery Centre as Potential Human Clinical Trials Partner
Neuralink, Elon Musk's brain implant company, is said to have approached one of the biggest US neurosurgery centres ahead of the company's plans to launch a human clinical trial for its devices that have been in development since 2016. The firm is working to address concerns expressed by the US Food and Drug Administration after it rejected an appl...
-
Neuralink Expected to Begin Human Clinical Trials in Six Months, Elon Musk Says
Neuralink is expected to begin human trials in six months, Elon Musk said on Wednesday. The brain chip interface is running behind schedule, and is said to have repeatedly missed internal deadlines to gain US Food and Drug Administration (FDA) approval to start human trials. Over a year ago, Neuralink demonstrated its technology on a monkey with a ...
-
US Health Regulator Clears Covaxin For Clinical Trials In Adults In America
Bharat Biotech's COVID-19 vaccine Covaxin has been given clearance for clinical trials in adults by the US Food and Drug Administration (FDA).
-
Bharat Biotech's US Partner Files Request With FDA For Covaxin Trials
Ocugen, Bharat Biotech's US partner for COVID-19 vaccine Covaxin, on Wednesday said it has submitted Investigational New Drug Application (IND) to the US Food and Drug Administration to conduct clinical trials.
-
Pig Organ Transplants May One Day Outperform Human Donors, Says Leading Surgeon
A US clinical trial using gene-edited pig kidneys has begun, with experts saying xenotransplantation could one day offer safer and more effective alternatives to human donor organs.
-
Elon Musk's Neuralink to Test Brain Chips in Clinical Study in Great Britain
Elon Musk's brain implant company Neuralink said on Thursday it will launch a clinical study in Great Britain to test how its chips can enable patients with severe paralysis to control digital and physical tools with their thoughts.
-
Can Artificial Intelligence Chatbots Really Improve Mental Health
Recently, I found myself pouring my heart out, not to a human, but to a chatbot named Wysa on my phone. It nodded - virtually - asked me how I was feeling and gently suggested trying breathing exercises.
-
Revolutionary New Drug Offers 99.9% Protection Against HIV
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high costs may limit its global impact.
-
FDA Approves Suzetrigine, First Non-Opioid Painkiller in Decades
The FDA has approved suzetrigine, a groundbreaking painkiller that blocks sodium channels to provide opioid-level pain relief without the risks of addiction, sedation, or overdose. Known as Journavx, this drug is the first in over two decades to introduce a new pain relief mechanism. Clinical trials showed it matched opioids in effectiveness but wi...
-
Elon Musk's Neuralink Gets FDA's 'Breakthrough Device' Tag for Implant Aimed at Restoring Vision
Elon Musk's brain-chip startup Neuralink said on Tuesday its experimental implant aimed at restoring vision received the US Food and Drug Administration's "breakthrough device" designation.
-
Neuralink Brain Chip Implant Wires Now Stable in First Patient, Musk Hopes for More Human Trials This Year
Neuralink's first brain chip implant in a human has stabalised, company executives have confirmed this week. The device works by using tiny wires, which are thinner than a human hair, to capture signals from the brain and translate those into actions such as moving a mouse cursor on a computer screen.
-
Elon Musk's Neuralink Receives Approval to Start Brain Implant Human Trial for Paralysis Patients
Billionaire entrepreneur Elon Musk's brain-chip startup Neuralink said on Tuesday it has received approval from an independent review board to begin recruitment for the first human trial of its brain implant for paralysis patients.
-
Jaden Pariat Selected For Ferrari Driver Academy Trials
Rising Indian motorsport star Jaden R Pariat has been invited to the Ferrari Driver Academy (FDA) selection trials, as one of the best young talents in the Asia Pacific and Oceania region
-
Opinion: Would You Let Elon Musk Implant A Device In Your Brain?
Elon Musk's Neuralink received approval last week from the US Food and Drug Administration to conduct human clinical trials, which one former FDA official called "really a big deal."
-
Elon Musk's Neuralink Says It Has FDA Approval for Study of Brain Implants in Humans
Elon Musk's brain-implant company Neuralink on Thursday said the US Food and Drug Administration (FDA) had given the green light to its first-in-human clinical trial, a critical milestone after earlier struggles to gain approval.
-
Neuralink Said to Approach US Neurosurgery Centre as Potential Human Clinical Trials Partner
Neuralink, Elon Musk's brain implant company, is said to have approached one of the biggest US neurosurgery centres ahead of the company's plans to launch a human clinical trial for its devices that have been in development since 2016. The firm is working to address concerns expressed by the US Food and Drug Administration after it rejected an appl...
-
Neuralink Expected to Begin Human Clinical Trials in Six Months, Elon Musk Says
Neuralink is expected to begin human trials in six months, Elon Musk said on Wednesday. The brain chip interface is running behind schedule, and is said to have repeatedly missed internal deadlines to gain US Food and Drug Administration (FDA) approval to start human trials. Over a year ago, Neuralink demonstrated its technology on a monkey with a ...
-
US Health Regulator Clears Covaxin For Clinical Trials In Adults In America
Bharat Biotech's COVID-19 vaccine Covaxin has been given clearance for clinical trials in adults by the US Food and Drug Administration (FDA).
-
Bharat Biotech's US Partner Files Request With FDA For Covaxin Trials
Ocugen, Bharat Biotech's US partner for COVID-19 vaccine Covaxin, on Wednesday said it has submitted Investigational New Drug Application (IND) to the US Food and Drug Administration to conduct clinical trials.
